Gaylon Kipp, MD

Board Certified Primary Care Physician

Dr. Gaylon Kipp, a Board-Certified primary care physician with over 30 years of experience, serves as a Principal Investigator at Northwest Clinical Research Center (NWCRC) in Bellevue, Washington. His extensive involvement in clinical research has led to the completion of over 65 studies across various medical indications.​ Clinical Trial Indications at NWCRC: NWCRC has actively participated in clinical trials across multiple therapeutic areas, including:​

• Depression: Conducted 117 studies, encompassing treatment-resistant depression and postpartum depression.​
• Anxiety Disorders: Completed 42 trials focusing on generalized anxiety disorder, panic disorder, post-traumatic stress disorder, and social anxiety disorder.​
• Bipolar Disorders: Engaged in 51 studies addressing bipolar mania, bipolar depression, and related conditions.​
• Psychotic Disorders: Performed 62 trials, including research on schizophrenia and borderline personality disorder.​
• Attention Deficit Hyperactivity Disorder (ADHD): Carried out 16 studies in adult populations and 105 in pediatric/adolescent groups.​
• Autism Spectrum Disorders: Executed 2 trials in adult subjects and 5 in pediatric/adolescent cases.​
• Obsessive-Compulsive Disorder (OCD): Completed 4 studies focusing on both adult and pediatric populations.​

This diverse portfolio highlights NWCRC’s comprehensive research capabilities across various psychiatric and neurological conditions. ​ Recent Research Highlights: In addition to the studies mentioned above, NWCRC has contributed to the development and assessment of over 30 medications that have reached the market, benefiting the scientific and medical communities. ​ Dr. Kipp’s dedication to patient care and research significantly enhances NWCRC’s role in advancing medical knowledge and improving treatment options across multiple health conditions.